A study to assess the effectiveness of cetrizine as an additional therapeutic agent to standard therapy,in comparison to placebo in limited patchy alopecia areata
Phase 3
- Conditions
- Health Condition 1: L639- Alopecia areata, unspecified
- Registration Number
- CTRI/2021/03/031832
- Lead Sponsor
- DrSarithaM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients diagnosed by consensus by investigators having limited patchy alopecia areata.
Exclusion Criteria
Patients on steroids or immunosuppressants for any other condition.
Pregnancy & lactation
Children less than 18 years
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method